共 50 条
- [2] EFFICACY OF HIGH-DOSE AND INTERMEDIATE-DOSE ARA-C IN PATIENTS WITH SECONDARY AML BLUT, 1986, 53 (03): : 141 - 141
- [4] TOXICITY OF SEQUENTIAL HIGH-DOSE ARA-C ASPARAGINASE TREATMENT IN CHILDHOOD POOR RISK LEUKEMIA BLUT, 1986, 53 (04): : 309 - 314
- [5] PHARMACOKINETICS OF HIGH-DOSE ARA-C (HIDAC) - A PHARMACOLOGIC MEANS FOR SELF POTENTIATION PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 130 - 130
- [7] MODULATION OF THE CELLULAR PHARMACOLOGY OF HIGH-DOSE ARA-C (HIDAC) BY ASPARAGINASE (ASNASE) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 409 - 409
- [9] SYNERGY BETWEEN ARA-C AND HIGH-LEVELS OF ARA-U (HIARAU) CONTRIBUTE TO THE THERAPEUTIC EFFICACY OF HIGH-DOSE ARA-C (HIDAC) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 302 - 302